Artificial intelligence (AI) in life sciences involves the application of AI technologies and techniques across various domains within the life sciences industry. The integration of AI aims to enhance and expedite processes, improve decision-making, and extract valuable insights from complex data sets.
The primary components of artificial intelligence in life sciences include software, hardware, and services. The software employs AI algorithms to analyze extensive chemical databases, predicting the likelihood of specific molecules binding to target receptors, thereby accelerating the drug discovery process. These software applications can be deployed through on-premises and cloud-based models and find applications in various domains such as drug discovery, medical diagnosis, biotechnology, clinical trials, precision and personalized medicine, and patient monitoring.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The artificial intelligence in life sciences market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in life sciences market statistics, including artificial intelligence in life sciences industry global market size, regional shares, competitors with artificial intelligence in life sciences market share, detailed artificial intelligence in life science market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence in life sciences industry. This artificial intelligence in life sciences market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.92 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 23.2%. The growth in the historic period can be attributed to increasing number of clinical trials, increasing adoption of ai in the domain of research and development, high emphasis on the development of precision medicine and personalized drugs.
The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be attributed to the increasing interest in real-time remote patient monitoring (rpm) systems, increasing demand for AI in drug discovery, the increasing adoption of ai in medical imaging analysis. Major trends in the forecast period include strategic partnership, product innovations, technological advancements, investments, research and developments.
The forecast of 23.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biomedical research by inflating prices of Artificial intelligence(AI)-driven genomic sequencing analyzers and drug interaction prediction platforms developed in the UK and Switzerland, resulting in slower scientific breakthroughs and higher Research and Developemnet (R&D) expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing interest in real-time remote patient monitoring (RPM) systems is set to drive the expansion of artificial intelligence in the life sciences market in the foreseeable future. Remote patient monitoring systems, characterized by technology-driven healthcare solutions, aim to monitor patients' health beyond traditional healthcare settings. In the life sciences domain, AI plays a pivotal role in remote patient monitoring, offering continuous, personalized, and data-driven insights that facilitate proactive healthcare management. A survey conducted by Vivalink, a US-based digital healthcare company, revealed a noteworthy surge in clinicians' adoption of remote patient monitoring (RPM), growing from 20% in 2021 to 81% in 2022, representing a substantial 305% increase. Consequently, the rising interest in real-time remote patient monitoring (RPM) systems is steering the growth of artificial intelligence in the life sciences market.
Leading companies operating in the artificial intelligence in the life sciences market are directing their efforts towards innovative products featuring technological advancements, exemplified by drug discovery software, to maintain their market standing. Drug discovery software comprises computer programs and applications tailored to assist researchers in the pharmaceutical and biotechnology sectors during the drug discovery process. In December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a revolutionary drug discovery software. Positioned as the first of its kind, AIDDISON integrates virtual molecule design with real-world manufacturability, leveraging generative AI, machine learning, and computer-aided drug design. AIDDISON excels in identifying drug candidates from a vast array of possibilities, considering essential properties such as non-toxicity and solubility. Its unique capability to bridge the gap between virtual molecule design and real-world manufacturability underscores a notable application of artificial intelligence in the life sciences sector.
In June 2023, Verix, a US-based company specializing in pharma commercial operations, completed the acquisition of Start-up.AI for an undisclosed sum. Verix's strategic move to acquire Start-up.AI aims to fortify its capabilities in artificial intelligence (AI) and machine learning (ML) within the pharmaceutical commercial operations sector. Start-up.ai, based in Israel, is a provider of an AI-driven commercial optimization platform, enhancing Verix's prowess in life science AI capabilities.
Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial intelligence (AI) in the life sciences market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial intelligence (AI) in the life sciences market consists of revenues earned by entities by private analytics, AI-driven clinical trial services, and real-world evidence services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the life sciences market also consists of sales of high-performance computing (HPC) clusters, edge computing devices, and IoT devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence In Life Sciences Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence in life sciences market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence in life sciences ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in life sciences market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Offering: Software; Hardware; Services
- 2) By Deployment: On-Premises; Cloud-Based
- 3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision And Personalized Medicine; Patient Monitoring
- Subsegments:
- 1) By Software: Drug Discovery Software; Genomic Analysis Software; Clinical Trial Management Software; Personalized Medicine Software; Laboratory Information Management Systems (LIMS)
- 2) By Hardware: AI-Enabled Laboratory Equipment; Robotics And Automation Systems; Imaging Devices And Equipment; Sensor Technologies
- 3) By Services: Consulting Services; Data Analytics Services; Research And Development Services; Implementation And Integration Services; Training And Support Services
- Companies Mentioned: Google LLC; Microsoft Corporation; Intel Corporation; IBM Corporation; Medtronic PLC; Nvidia Corporation; Novo Nordisk A/S; Siemens Healthineers AG; Philips Healthcare; Babylon Healthcare Services Ltd.; Komodo Health Inc.; Modernizing Medicine Inc.; Viz.ai Inc.; Butterfly Network Inc.; Augmedix; AiCure LLC; HealthTap Inc.; Welltok Inc.; Enlitic Inc.; PathAI Inc.; Nano-X Imaging Ltd.; Berg LLC; Insitro; Sense.ly Inc.; Subtle Medical Inc.; Medasense Biometrics Limited; Immunai; Atomwise Inc.; Freenome Holdings Inc.; CloudMedX Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artificial Intelligence In Life Sciences Market Characteristics
3. Artificial Intelligence In Life Sciences Market Trends And Strategies
4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Artificial Intelligence In Life Sciences Growth Analysis And Strategic Analysis Framework
- 5.1. Global Artificial Intelligence In Life Sciences PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Artificial Intelligence In Life Sciences Market Growth Rate Analysis
- 5.4. Global Artificial Intelligence In Life Sciences Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Artificial Intelligence In Life Sciences Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Artificial Intelligence In Life Sciences Total Addressable Market (TAM)
6. Artificial Intelligence In Life Sciences Market Segmentation
- 6.1. Global Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software
- Hardware
- Services
- 6.2. Global Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- On-Premises
- Cloud-Based
- 6.3. Global Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Discovery
- Medical Diagnosis
- Biotechnology
- Clinical Trials
- Precision And Personalized Medicine
- Patient Monitoring
- 6.4. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drug Discovery Software
- Genomic Analysis Software
- Clinical Trial Management Software
- Personalized Medicine Software
- Laboratory Information Management Systems (LIMS)
- 6.5. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- AI-Enabled Laboratory Equipment
- Robotics And Automation Systems
- Imaging Devices And Equipment
- Sensor Technologies
- 6.6. Global Artificial Intelligence In Life Sciences Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consulting Services
- Data Analytics Services
- Research And Development Services
- Implementation And Integration Services
- Training And Support Services
7. Artificial Intelligence In Life Sciences Market Regional And Country Analysis
- 7.1. Global Artificial Intelligence In Life Sciences Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Artificial Intelligence In Life Sciences Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artificial Intelligence In Life Sciences Market
- 8.1. Asia-Pacific Artificial Intelligence In Life Sciences Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence In Life Sciences Market
- 9.1. China Artificial Intelligence In Life Sciences Market Overview
- 9.2. China Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence In Life Sciences Market
- 10.1. India Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence In Life Sciences Market
- 11.1. Japan Artificial Intelligence In Life Sciences Market Overview
- 11.2. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence In Life Sciences Market
- 12.1. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence In Life Sciences Market
- 13.1. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence In Life Sciences Market
- 14.1. South Korea Artificial Intelligence In Life Sciences Market Overview
- 14.2. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence In Life Sciences Market
- 15.1. Western Europe Artificial Intelligence In Life Sciences Market Overview
- 15.2. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence In Life Sciences Market
- 16.1. UK Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artificial Intelligence In Life Sciences Market
- 17.1. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artificial Intelligence In Life Sciences Market
- 18.1. France Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artificial Intelligence In Life Sciences Market
- 19.1. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artificial Intelligence In Life Sciences Market
- 20.1. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence In Life Sciences Market
- 21.1. Eastern Europe Artificial Intelligence In Life Sciences Market Overview
- 21.2. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence In Life Sciences Market
- 22.1. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence In Life Sciences Market
- 23.1. North America Artificial Intelligence In Life Sciences Market Overview
- 23.2. North America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence In Life Sciences Market
- 24.1. USA Artificial Intelligence In Life Sciences Market Overview
- 24.2. USA Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artificial Intelligence In Life Sciences Market
- 25.1. Canada Artificial Intelligence In Life Sciences Market Overview
- 25.2. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence In Life Sciences Market
- 26.1. South America Artificial Intelligence In Life Sciences Market Overview
- 26.2. South America Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence In Life Sciences Market
- 27.1. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence In Life Sciences Market
- 28.1. Middle East Artificial Intelligence In Life Sciences Market Overview
- 28.2. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence In Life Sciences Market
- 29.1. Africa Artificial Intelligence In Life Sciences Market Overview
- 29.2. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Artificial Intelligence In Life Sciences Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence In Life Sciences Market Competitive Landscape And Company Profiles
- 30.1. Artificial Intelligence In Life Sciences Market Competitive Landscape
- 30.2. Artificial Intelligence In Life Sciences Market Company Profiles
- 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
31. Artificial Intelligence In Life Sciences Market Other Major And Innovative Companies
- 31.1. Nvidia Corporation
- 31.2. Novo Nordisk A/S
- 31.3. Siemens Healthineers AG
- 31.4. Philips Healthcare
- 31.5. Babylon Healthcare Services Ltd.
- 31.6. Komodo Health Inc.
- 31.7. Modernizing Medicine Inc.
- 31.8. Viz.ai Inc.
- 31.9. Butterfly Network Inc.
- 31.10. Augmedix
- 31.11. AiCure LLC
- 31.12. HealthTap Inc.
- 31.13. Welltok Inc.
- 31.14. Enlitic Inc.
- 31.15. PathAI Inc.
32. Global Artificial Intelligence In Life Sciences Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artificial Intelligence In Life Sciences Market
34. Recent Developments In The Artificial Intelligence In Life Sciences Market
35. Artificial Intelligence In Life Sciences Market High Potential Countries, Segments and Strategies
- 35.1 Artificial Intelligence In Life Sciences Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Artificial Intelligence In Life Sciences Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Artificial Intelligence In Life Sciences Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
